Work

Anti-idiotypic antibody and recombinant antigen vaccines in colorectal cancer patients

Year: 2001

Type: article

Source: Critical Reviews in Oncology/Hematology

DOI: 10.1016/s1040-8428(01)00125-1

Authors: Brigitte Birebent, Rajasekharan Somasundaram, Enkhtsetseg Purev, Weiping Li, Edith Mitchell, Diane Hoey, Ellen Bloom, Michael Mastrangelo, Henry Maguire, David T. Harris, Ludger Staib, Heidi Braumuller, Christian Leeser, Norbert Kuttner, Hans-Gunther Beger, Dorothee Herlyn

Institutions: The Wistar Institute, Thomas Jefferson University, Lankenau Medical Center, Universität Ulm

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: PHASE I CLINICAL TRIAL WITH MONOCLONAL ANTI-IDIOTYPE, G3471318205, G5029023592, CO17 1A/GA733 ANTIGEN IN COLORECTAL CANCER THERAPY, G7490211573, Consolidated Basic Cancer Research Program, G991237949

OpenAlex ID: W2010107806

FWCI: 0.97

Cites: 47

Cited by: 24

Related to: 10